Susan D. DeVore - 27 May 2021 Form 4 Insider Report for Unum Group (UNM)

Role
Director
Signature
/s/ Jullienne, J. Paul, Attorney-in-Fact
Issuer symbol
UNM
Transactions as of
27 May 2021
Net transactions value
$0
Form type
4
Filing time
01 Jun 2021, 18:48:23 UTC
Next filing
05 Aug 2021

Quoteable Key Fact

"Susan D. DeVore filed Form 4 for Unum Group (UNM) on 01 Jun 2021."

Quick Takeaways

  • This page summarizes Susan D. DeVore's Form 4 filing for Unum Group (UNM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 01 Jun 2021, 18:48.

What Changed

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UNM Common Stock Award $0 +5,170 +25% $0.000000 25,543 27 May 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All are restricted stock units ("RSUs") vesting on May 27, 2022.
F2 Includes 15,732 RSUs and 9,810 shares of common stock. All RSUs may be settled, on a 1-for-1 basis, only in shares of common stock. Fractional amounts have been rounded to the nearest whole number.
F3 Beneficial ownership amount accounts for the exempt acquisitions of an aggregate of 512.417 RSUs pursuant to the reinvestment of dividends since the date of the reporting person's prior Form 4.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .